Authored by Dr Karthik Ramasamy, Oxford University Hospitals NHS Trust, Associate Professor of Haematology & Consultant Haematologist - Dr Jenny Bird, Bristol Haematology and Oncology Centre, Consultant Haematologist - Professor Mark Drayson, University Hospital Birmingham & Heartlands Hospital, Emeritus Professor of Clinical Immunodiagnostics and Honorary Consultant Immunologist - Lisa Ferguson, Oxford University Hospitals NHS Foundation Trust, Myeloma Advanced Nurse Practitioner - Dr Simon Stern, Epsom & St Helier University Hospitals NHS Trust, Consultant Haematologist - Myeloma UK
Authored by Prof. Ashutosh Wechalekar, University College London and the Royal Free London NHS Foundation Trust, UK, Professor of Medicine and Haematology - Dr Christopher Parrish, Leeds Teaching Hospitals NHS Trust, UK, Consultant Haematologist - Prof. Efstathios Kastritis, National and Kapodistrian University of Athens, School of Medicine, Greece, Professor of Clinical Therapeutics/Medical Oncology - Dr Jennifer Pinney, University Hospitals Birmingham NHS Foundation Trust, UK, Consultant Nephrologist - Dr Carol Whelan, Royal Free London NHS Foundation Trust, UK, Consultant Cardiologist - Prof. Giovanni Palladini, Amyloidosis Research and Treatment Center, University Hospital San Matteo, Pavia, Italy, Acting Director of the Amyloidosis Research and Treatment Center - Prof. Guy Pratt, University Hospitals Birmingham, UK, Consultant Haematologist - Myeloma UK
